Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate versus propofol for recovery quality after painless gastroscopy
ChiCTR2000034191Phase 4Not yet recruiting
- Sponsor
- Subei People's Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam (2 arms), sponsored by Subei People's Hospital. Primary endpoints: Incidence, severity, and duration of 12 major postoperative discomfort symptoms, Incidence, severity, and duration of other postoperative discomfort symptoms and 1 more. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2000034191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034191.